BNF 82 (British National Formulary) September 2021: 82: September 2021 - March 2022

£29.975
FREE Shipping

BNF 82 (British National Formulary) September 2021: 82: September 2021 - March 2022

BNF 82 (British National Formulary) September 2021: 82: September 2021 - March 2022

RRP: £59.95
Price: £29.975
£29.975 FREE Shipping

In stock

We accept the following payment methods

Description

In general, drug and product names should be written in full. Unofficial abbreviations should not be used as they may be misinterpreted. Non-proprietary titles Many of the unprotected titles used in this book are the titles of the monographs of the European Pharmacopoeia, the British Pharmacopoeia or the British Pharmaceutical Code 1973. In such cases, the products must comply with the standard (if any) of the relevant publication, if necessary. . under the Medicinal Products for Human Use Regulation 2012. Custom titles BNF is a joint publication of the British Medical Association and the Royal Pharmaceutical Society. It is issued under the auspices of a Joint Formulation Committee composed of representatives of two professional bodies, the British Health Departments, the Agency for the Regulation of Medicines and Medical Products and the manufacturer of national guidelines. Dental Advisory Group oversees the preparation of dental and oral treatment management advice; the group includes representatives of the British Dental Association and representatives of the British Health Departments. The Prescribing Physicians Advisory Group provides advice on nurse-related content and includes representatives from different parts of the nursing community and the UK's health departments. Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017)

Names used as monograph names may be used freely in the United Kingdom, but may be banned in other countries. Blood Results in Clinical Practice: A Practical Guide to Interpreting Blood Test Results - 2nd ed. (2019)

Need help with your order?

As an example, here's a reference for the whole print BNF in Harvard format (remember, though, that you will probably be referencing a specific entry): Different programmes use different referencing styles, but basic principles are the same with two key elements: In-text citations On all programmes, it is essential to reference everything you use in your written work. Any time you quote from, summarise, paraphrase or discuss something you have read, listened to or watched, you should reference it. This tells the reader where your information comes from, and it ensures that you are not plagiarising (using someone else's words or work without credit). National Institute for Health and Care Excellence (2020) Acute coronary syndromes. NG185. Available at:https://www.nice.org.uk/guidance/ng185(Accessed: 7 December 2020). Mylan. Acamprosate 333 mg Gastro-resistant Tablets SmPC. 2020 [cited 2020 Dec 4]Available from: https://www.medicines.org.uk/emc/product/2729/smpc

Drug information is taken from the manufacturers' product literature, medical and pharmaceutical literature, UK health departments, regulators and professional bodies. The advice is taken from the clinical literature and reflects, where possible, evaluations of evidence from a variety of sources. BNF also considers national guidelines and increased safety care to be authoritative. In addition, the newsroom received advice in all areas of treatment from specialist clinics; this ensures that BNF's recommendations are relevant to practice. Livtencity® [maribavir] for cytomegalovirus disease in recipients of haematopoietic stem cell transplant or solid organ transplant As noted in the British National Formulary (BNF) the recommended dosage for children under 12 is...(Joint Formulary Committee, 2021)." If unprotected ("generic") names are provided, they should be used in prescribing. This allows any suitable product to be delivered, thus saving patient delays and sometimes healthcare costs. The only exception is when there is a difference in clinical effect between each version of the product, which is important so that the patient always receives the same brand; in such cases, the brand or manufacturer name must be given. Non-proprietary names should not often be devised for prescribing, as this can lead to confusion, especially in the case of compound and controlled release products.Management of iron deficiency anaemia, including update to oral iron dosing and monitoring based on British Society of Gastroenterology guidelines In the body of your text, an indication of where the information for a specific sentence or quote comes from. Depending on which referencing style you use, this might be the name of the author of the information source and the year it was written, or it might be a number. For example, Harvard uses author and date, whereas Vancouver uses a number system. Reference list Ibrutinib (Imbruvica®): new risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events Adrenaline/epinephrine: recall of Emerade® 500 micrograms and Emerade® 300 micrograms auto-injectors, due to the potential for device failure [National Patient Safety Alert advice]



  • Fruugo ID: 258392218-563234582
  • EAN: 764486781913
  • Sold by: Fruugo

Delivery & Returns

Fruugo

Address: UK
All products: Visit Fruugo Shop